This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The new online Learning Center with new content can still be found under the “Training” folder on ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...